Nutraplus India Ltd

₹ 2.10 5.00%

13 Dec 2021

nutraplusindia.com BSE: 524764

About

Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.

[ edit about ]

[ add key points ]

Website BSE

Market Cap ₹ 7.16 Cr.
Current Price ₹ 2.10
High / Low ₹ /
Stock P/E
Book Value ₹ 17.0
Dividend Yield 0.00 %
ROCE 3.00 %
ROE -2.97 %
Face Value ₹ 5.00

Add ratio to table

Edit ratios

Pros

Stock is trading at 0.12 times its book value

Cons

Company has low interest coverage ratio.
Contingent liabilities of Rs.3.89 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2011	Mar 2012	Jun 2012	Sep 2012	Dec 2012	Sep 2013	Dec 2013	Mar 2014	Jun 2014	Sep 2014	Dec 2014	Mar 2015	Jun 2015
	12.83	7.98	10.52	20.01	9.07	15.78	15.83	19.57	17.46	12.68	16.57	18.34	15.28
	10.68	7.20	9.66	17.79	7.87	13.07	14.14	14.63	14.94	18.27	12.51	16.12	12.52
Operating Profit	2.15	0.78	0.86	2.22	1.20	2.71	1.69	4.94	2.52	-5.59	4.06	2.22	2.76
OPM %	16.76%	9.77%	8.17%	11.09%	13.23%	17.17%	10.68%	25.24%	14.43%	-44.09%	24.50%	12.10%	18.06%
	0.02	0.12	0.03	0.05	0.02	0.02	0.02	0.03	0.04	-23.25	0.03	0.12	0.03
Interest	0.33	0.42	0.45	1.01	0.34	0.42	0.35	2.36	0.74	1.14	2.00	0.64	0.52
Depreciation	0.33	0.16	0.25	0.45	0.24	0.55	0.41	0.41	0.52	0.11	0.32	0.46	0.37
Profit before tax	1.51	0.32	0.19	0.81	0.64	1.76	0.95	2.20	1.30	-30.09	1.77	1.24	1.90
Tax %	27.81%	106.25%	42.11%	60.49%	34.38%	30.68%	35.79%	46.82%	21.54%	0.00%	8.47%	-162.90%	20.53%
	1.09	-0.02	0.12	0.32	0.42	1.23	0.61	1.17	1.03	-30.09	1.63	3.26	1.51
EPS in Rs	0.96	-0.02	0.11	0.26	0.34	0.95	0.47	0.90	0.79	-23.15	1.12	1.33	0.57
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2014	Mar 2015	TTM
	45	62	65	63
	38	51	62	59
Operating Profit	6	10	3	3
OPM %	14%	17%	5%	5%
	0	0	-3	-23
Interest	2	4	5	4
Depreciation	1	2	1	1
Profit before tax	4	5	-6	-25
Tax %	31%	39%	28%
	3	3	-4	-24
EPS in Rs	2.59	2.41	-1.66	-20.13
Dividend Payout %	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	13%
TTM:	-8%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-111%

Stock Price CAGR
10 Years:	-10%
5 Years:	-33%
3 Years:	-4%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	-3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2014	Mar 2015
Equity Capital	5	6	11
Reserves	8	14	31
	15	32	40
	16	23	32
Total Liabilities	44	75	114
	19	36	23
CWIP	0	1	13
Investments	2	0	4
	23	39	74
Total Assets	44	75	114

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015
	4	-16
	-11	-5
	7	32
Net Cash Flow	0	10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2014	Mar 2015
Debtor Days	98	88	75
Inventory Days	82	170	134
Days Payable	151	168	187
Cash Conversion Cycle	30	89	22
Working Capital Days	57	84	174
ROCE %			3%

Shareholding Pattern

Numbers in percentages

	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020
	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%	40.07%
	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
	59.91%	59.91%	59.91%	59.91%	59.91%	59.90%	59.90%	59.90%	59.91%	59.90%	59.91%	59.91%
No. of Shareholders	8,088	7,878	7,842	7,816	7,828	7,843	7,811	7,805	7,817	7,750	7,724	7,943

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Jun 2020
	40.07%	40.07%	40.07%	40.07%	40.07%
	0.13%	0.00%	0.00%	0.00%	0.00%
	0.02%	0.03%	0.03%	0.03%	0.03%
	59.78%	59.91%	59.90%	59.91%	59.91%
No. of Shareholders	8,013	7,842	7,811	7,724	7,943

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Nutraplus India Ltd

Nutraplus India Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls